Windmueller H G, Spaeth A E
J Lipid Res. 1985 Jan;26(1):70-81.
Studies using rat livers perfused with recycled, serum-containing medium plus [3H]leucine revealed that secreted VLDL contain three forms of apolipoprotein B (apoB), B-48, B-95, and B-100, all synthesized by the liver. The B-48/(B-95 + B-100) [3H]leucine incorporation ratio ranged from 0.22 to 3.25 with livers of rats fed different diets, and the ratio was positively correlated with the triglyceride secretion rate in most of the livers. Generally, as more triglyceride was secreted, a greater proportion was packaged with B-48, which is the apoB form most rapidly cleared from the circulation. Together, these findings suggest a mechanism for regulating plasma triglyceride levels. [3H]Leucine incorporation into apoA-I also was positively correlated with the triglyceride secretion rate. Secretion of newly synthesized B-48 was delayed relative to all other apolipoproteins. There was little segregation of any of the three apoB forms into any of five subfractions of secreted VLDL separated on the basis of Sf value; only the smallest VLDL (Sf 20-100) were slightly enriched in B-95 and B-100. Less than 5% of newly synthesized apoB appeared in perfusate LDL. The B-100/B-95 [3H]leucine incorporation ratio was 3.3 with perfused livers of fed rats but only 1.6 in post-surgical, relatively fasted rats in vivo, suggesting physiologic regulation also of the relative amounts of the two large apoBs produced. With recycled serum-free perfusate, as opposed to serum-containing medium, there was hepatic reuptake of nascent VLDL, indicated by the reuptake of newly synthesized apoE and all three forms of apoB, and not other apolipoproteins. Divergent metabolism of B-100 and B-95 in the rat was evident from the following results: a) B-95 disappeared more rapidly from recycled, serum-free liver perfusate; b) B-100 disappeared more rapidly from the circulation in vivo; c) plasma lipoprotein fractions of increasing density between d less than 1.019 and d 1.072 g/ml contained increasing proportions of B-95 over B-100. In summary, these results show that hepatic VLDL production in the rat involves the biosynthesis of three forms of apoB, that the relative amounts produced are regulated by physiologic variables, and that there is divergent metabolism of the VLDL particles into which these different apoB forms, either individually or in combination, become incorporated.
使用灌注有循环含血清培养基加[³H]亮氨酸的大鼠肝脏进行的研究表明,分泌的极低密度脂蛋白(VLDL)含有三种载脂蛋白B(apoB)形式,即B - 48、B - 95和B - 100,它们均由肝脏合成。用不同饮食喂养的大鼠肝脏,其B - 48/(B - 95 + B - 100)[³H]亮氨酸掺入率在0.22至3.25之间,并且该比率在大多数肝脏中与甘油三酯分泌率呈正相关。一般来说,随着甘油三酯分泌量增加,更多比例的甘油三酯与B - 48结合包装,B - 48是从循环中清除最快的apoB形式。这些发现共同提示了一种调节血浆甘油三酯水平的机制。[³H]亮氨酸掺入载脂蛋白A - I也与甘油三酯分泌率呈正相关。新合成的B - 48的分泌相对于所有其他载脂蛋白延迟。基于Sf值分离的分泌型VLDL的五个亚组分中,三种apoB形式中的任何一种都几乎没有分离;只有最小的VLDL(Sf 20 - 100)中B - 95和B - 100略有富集。新合成的apoB中不到5%出现在灌注液中的低密度脂蛋白(LDL)中。喂食大鼠的灌注肝脏中B - 100/B - 95 [³H]亮氨酸掺入率为3.3,但在术后相对禁食的大鼠体内仅为1.6,这表明两种大的apoB产生的相对量也受到生理调节。与含血清培养基相反,使用循环无血清灌注液时,肝脏对新生VLDL有摄取,这通过新合成的载脂蛋白E和所有三种apoB形式的摄取得以表明,而其他载脂蛋白则没有。大鼠中B - 100和B - 95的不同代谢从以下结果中明显可见:a)B - 95在循环无血清肝脏灌注液中消失得更快;b)B - 100在体内循环中消失得更快;c)在密度小于1.019至1.072 g/ml之间密度增加的血浆脂蛋白组分中,B - 95相对于B - 100的比例增加。总之,这些结果表明大鼠肝脏VLDL的产生涉及三种apoB形式的生物合成,产生的相对量受生理变量调节,并且这些不同的apoB形式单独或组合掺入的VLDL颗粒存在不同的代谢。